Directory

>

Linda Vocila

Linda Vocila

Executive Director, Clinical Strategy | Translational Drug Development (TD2)

United States

View contact details (it's free)

Linda Vocila

Summary

Linda Vocila is an accomplished Executive Director in Clinical Strategy at Translational Drug Development, where she has been instrumental since July 2016. With a solid background in commercial physical research, she brings a wealth of experience to her role, driving innovative strategies in clinical development. Linda's leadership in a smaller organization, where she plays a pivotal role in shaping research directions, showcases her adaptability and strategic thinking. Although her profile lacks formal education and awards, her extensive experience in the industry speaks volumes about her capabilities. As a Director, she is likely to have a significant influence on the company’s direction and success. Her commitment to advancing drug development processes is evident in her long tenure at TD2. Linda is poised to leverage her expertise to foster collaborations and drive impactful research outcomes.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Linda Vocila

Work Experience

company logo

Executive Director, Clinical Strategy at

Translational Drug Development (TD2)

July 2016 - Present

Logos provided by Logo.dev

Frequently Asked Questions about Linda Vocila

What is Linda Vocila email address?

Linda Vocila's primary email address is *******@td2inc.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Linda Vocila work for?

Linda Vocila is a Executive Director, Clinical Strategy at Translational Drug Development (TD2), a company specializing in Commercial physical research.

How can I directly contact Linda Vocila?

To contact Linda Vocila directly, you can use the email address *******@td2inc.com. Complete contact information is available upon registration with Muraena.

Who is Linda Vocila?

Linda Vocila is an accomplished Executive Director in Clinical Strategy at Translational Drug Development, where she has been instrumental since July 2016. With a solid background in commercial physical research, she brings a wealth of experience to her role, driving innovative strategies in clinical development. Linda's leadership in a smaller organization, where she plays a pivotal role in shaping research directions, showcases her adaptability and strategic thinking. Although her profile lacks formal education and awards, her extensive experience in the industry speaks volumes about her capabilities. As a Director, she is likely to have a significant influence on the company’s direction and success. Her commitment to advancing drug development processes is evident in her long tenure at TD2. Linda is poised to leverage her expertise to foster collaborations and drive impactful research outcomes.

Linda`s contact details

mail

*******@td2inc.com

Colleagues

avatar
Susan Night

Sr. Vice President, Strategy and Growth

avatar
Susan Tessmann

Vice President Clinical Development

avatar
Jenny Keppler

Vice President, Translational Medicine

View Contact details (it's free)
Request Profile Removal